Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination.
Reads0
Chats0
TLDR
For example, the Norwegian Medicines Agency (NOMA) investigated 13 of the deaths so far and concluded that common adverse reactions of mRNA vaccines, such as cancer, were not linked to the vaccine as discussed by the authors.Abstract:
Doctors in Norway have been told to conduct more thorough evaluations of very frail elderly patients in line to receive the Pfizer BioNTec vaccine against covid-19, following the deaths of 23 patients shortly after receiving the vaccine.
“It may be a coincidence, but we aren’t sure,” Steinar Madsen, medical director of the Norwegian Medicines Agency (NOMA), told The BMJ . “There is no certain connection between these deaths and the vaccine.”
The agency has investigated 13 of the deaths so far and concluded that common adverse reactions of mRNA vaccines, such …read more
Citations
More filters
Journal ArticleDOI
Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.
TL;DR: In this paper, a randomized, cross-sectional study was performed to investigate the side effects of the BNT162b2 vaccine using an independent online questionnaire gathering responses from healthcare workers (HCWs) with detailed review of organ systems.
Journal ArticleDOI
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
Nicholas G. Kounis,Ioanna Koniari,Cesare de Gregorio,Dimitris Velissaris,Konstantinos Petalas,Aikaterini Brinia,Stelios F Assimakopoulos,Christos Gogos,Sophia N. Kouni,George N. Kounis,Gianfranco Calogiuri,Ming Yow Hung +11 more
TL;DR: A review of the current state of knowledge of immediate and delayed allergic reactions in the currently available vaccines against COVID-19, together with the general and specific therapeutic considerations is presented in this paper.
Journal ArticleDOI
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
TL;DR: Two lipid nanoparticle (LNP)-based mRNA vaccines (Pfizer-BioNTech and Moderna) against SARS-CoV-2 have already received emergency use authorization by the US Food and Drug Administration (FDA).
Journal ArticleDOI
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
Rimple Jeet Kaur,Siddhartha Dutta,Jaykaran Charan,Pankaj Bhardwaj,Ankita Tandon,Dharamveer Yadav,Salequl Islam,Mainul Haque +7 more
TL;DR: In this paper, the authors focused on cardiovascular adverse events post-COVID-19 vaccination and aims to determine adverse events with the administered vaccine, and extracted the cardiovascular (CVS) adverse events were extracted for three broad headings (SOCs) - cardiac disorders, vascular disorders, and investigations.
Journal ArticleDOI
COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries.
Li Ping Wong,Li Ping Wong,Haridah Alias,Mahmoud Danaee,Jamil Ahmed,Abhishek Lachyan,Abhishek Lachyan,Carla Zi Cai,Yulan Lin,Zhijian Hu,Si Ying Tan,Yixiao Lu,Guoxi Cai,Di Khanh Nguyen,Farhana Nishat Seheli,Fatma Alhammadi,Milkar D. Madhale,Muditha Atapattu,Tasmi Quazi-Bodhanya,Samira Mohajer,Gregory D. Zimet,Qinjian Zhao +21 more
TL;DR: In this paper, an anonymous cross-sectional survey was conducted between 4 January and 5 March 2021 in 17 countries worldwide to assess global COVID-19 vaccination intention, vaccine characteristics and desirable vaccine characteristics influencing the choice of vaccines.
Related Papers (5)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P. Polack,Stephen J. Thomas,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Pérez Marc,Edson D. Moreira,Cristiano Zerbini,Ruth Bailey,Kena A. Swanson,Satrajit Roychoudhury,Kenneth Koury,Ping Li,Warren Kalina,David A. Cooper,Robert W. Frenck,Laura L. Hammitt,Özlem Türeci,Haylene Nell,Axel Schaefer,Serhat Ünal,Dina B. Tresnan,Susan Mather,Philip R. Dormitzer,Ugur Sahin,Kathrin U. Jansen,William C. Gruber +28 more
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R. Baden,Hana M. El Sahly,Brandon Essink,Karen L. Kotloff,Sharon E. Frey,Rick Novak,David Diemert,Stephen A. Spector,Nadine Rouphael,C. Buddy Creech,John W McGettigan,Shishir Khetan,Nathan Segall,Joel Solis,Adam Brosz,Carlos Fierro,Howard J. Schwartz,Kathleen M. Neuzil,Lawrence Corey,Peter B. Gilbert,Holly Janes,Dean Follmann,Mary A. Marovich,John R. Mascola,Laura Polakowski,Julie E. Ledgerwood,Barney S. Graham,Hamilton Bennett,Rolando Pajon,Conor Knightly,Brett Leav,Weiping Deng,Honghong Zhou,Shu Liang Han,Melanie Ivarsson,Jacqueline Miller,Tal Z Zaks +36 more
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey,Clemens Sac.,Shabir A. Madhi,Lily Yin Weckx,P M Folegatti,Parvinder K. Aley,Brian Angus,Vicky L. Baillie,Shaun Barnabas,Q E Bhorat,S Bibi,Carmen Briner,P Cicconi,Andrea M. Collins,R Colin-Jones,Clare L. Cutland,Thomas C. Darton,Keertan Dheda,Duncan Cja.,Emary Krw.,Katie J. Ewer,Lee Fairlie,Saul N. Faust,Shuo Feng,Daniela M. Ferreira,Adam Finn,Anna Goodman,Catherine M. Green,Christopher A Green,Paul T. Heath,Christopher Hill,Helen Hill,Ian Hirsch,Hodgson Shc.,Allen Izu,S Jackson,D Jenkin,Joe Ccd.,S Kerridge,Anthonet Koen,Gaurav Kwatra,Rajeka Lazarus,Alison M. Lawrie,A Lelliott,Vincenzo Libri,Patrick J. Lillie,R Mallory,Mendes Ava.,Eveline Pipolo Milan,Angela M. Minassian,Alastair McGregor,Hazel Morrison,Y Mujadidi,Amit J Nana,P J O’Reilly,S D Padayachee,A Pittella,E Plested,Katrina M Pollock,M N Ramasamy,S Rhead,Alexandre Vargas Schwarzbold,Nisha Singh,Andrew Smith,R Song,Matthew D. Snape,Eduardo Sprinz,Rebecca K. Sutherland,R Tarrant,E. Thomson,M E Török,Mark Toshner,Turner Dpj.,Johan Vekemans,Tonya Villafana,Watson Mee.,C J Williams,Alexander D. Douglas,Hill Avs.,Teresa Lambe,Sarah C. Gilbert,Andrew J. Pollard +81 more